| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.0009 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.002 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |